317 related articles for article (PubMed ID: 27222549)
1. Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.
Adams TD; Arterburn DE; Nathan DM; Eckel RH
Diabetes Care; 2016 Jun; 39(6):912-23. PubMed ID: 27222549
[TBL] [Abstract][Full Text] [Related]
2. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2.
Cummings DE; Cohen RV
Diabetes Care; 2016 Jun; 39(6):924-33. PubMed ID: 27222550
[TBL] [Abstract][Full Text] [Related]
3. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis.
Sheng B; Truong K; Spitler H; Zhang L; Tong X; Chen L
Obes Surg; 2017 Oct; 27(10):2724-2732. PubMed ID: 28801703
[TBL] [Abstract][Full Text] [Related]
4. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.
Sjöström L; Peltonen M; Jacobson P; Ahlin S; Andersson-Assarsson J; Anveden Å; Bouchard C; Carlsson B; Karason K; Lönroth H; Näslund I; Sjöström E; Taube M; Wedel H; Svensson PA; Sjöholm K; Carlsson LM
JAMA; 2014 Jun; 311(22):2297-304. PubMed ID: 24915261
[TBL] [Abstract][Full Text] [Related]
5. Bariatric surgery for type 2 diabetes: to whom and when?
Samaras K
Minerva Endocrinol; 2013 Mar; 38(1):47-58. PubMed ID: 23435442
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis.
Yan G; Wang J; Zhang J; Gao K; Zhao Q; Xu X
PLoS One; 2019; 14(12):e0224828. PubMed ID: 31794559
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Changes and Diabetes Microvascular Complications 5 Years After Obesity Surgery.
Miras AD; Ravindra S; Humphreys A; Lascaratos G; Quartey KNK; Ahmed AR; Cousins J; Moorthy K; Purkayastha S; Hakky S; Tan T; Chahal HS
Obes Surg; 2019 Dec; 29(12):3907-3911. PubMed ID: 31372874
[TBL] [Abstract][Full Text] [Related]
8. Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study.
O'Brien R; Johnson E; Haneuse S; Coleman KJ; O'Connor PJ; Fisher DP; Sidney S; Bogart A; Theis MK; Anau J; Schroeder EB; Arterburn D
Ann Intern Med; 2018 Sep; 169(5):300-310. PubMed ID: 30083761
[TBL] [Abstract][Full Text] [Related]
9. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
Cerveny JD; Leder RD; Weart CW
Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
[TBL] [Abstract][Full Text] [Related]
10. The long-term effect of bariatric/metabolic surgery versus pharmacologic therapy in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Yang Y; Miao C; Wang Y; He J
Diabetes Metab Res Rev; 2024 Jul; 40(5):e3830. PubMed ID: 38873748
[TBL] [Abstract][Full Text] [Related]
11. Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.
Yska JP; van Roon EN; de Boer A; Leufkens HG; Wilffert B; de Heide LJ; de Vries F; Lalmohamed A
JAMA Surg; 2015 Dec; 150(12):1126-33. PubMed ID: 26422580
[TBL] [Abstract][Full Text] [Related]
12. Bariatric surgery versus medications in the treatment of type 2 diabetes.
Fanin A; Benetti A; Ceriani V; Pontiroli AE
Minerva Endocrinol; 2015 Dec; 40(4):297-306. PubMed ID: 26365477
[TBL] [Abstract][Full Text] [Related]
13. Effect of revisional bariatric surgery on type 2 diabetes mellitus.
Aleassa EM; Hassan M; Hayes K; Brethauer SA; Schauer PR; Aminian A
Surg Endosc; 2019 Aug; 33(8):2642-2648. PubMed ID: 30341657
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in bariatric surgery.
Stenberg E; Thorell A
Curr Opin Clin Nutr Metab Care; 2020 Jul; 23(4):255-261. PubMed ID: 32205577
[TBL] [Abstract][Full Text] [Related]
15. Bariatric surgery for obesity and metabolic disorders: state of the art.
Nguyen NT; Varela JE
Nat Rev Gastroenterol Hepatol; 2017 Mar; 14(3):160-169. PubMed ID: 27899816
[TBL] [Abstract][Full Text] [Related]
16. Bariatric surgery: an attractive therapeutic modality for type 2 diabetes mellitus.
Dugum M; El-Hayek K; Garg S
Diabetes Technol Ther; 2014 Sep; 16(9):547-9. PubMed ID: 25068437
[No Abstract] [Full Text] [Related]
17. The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery.
Zaman JA; Shah N; Leverson GE; Greenberg JA; Funk LM
Surg Endosc; 2017 Mar; 31(3):1407-1413. PubMed ID: 27450209
[TBL] [Abstract][Full Text] [Related]
18. Microvascular complications of obesity and diabetes-Role of bariatric surgery.
Bashir B; Iqbal Z; Adam S; Ferdousi M; Chick W; Hussein HA; Syed AA; Le Roux CW; Cohen RV; Malik RA; Soran H
Obes Rev; 2023 Oct; 24(10):e13602. PubMed ID: 37515402
[TBL] [Abstract][Full Text] [Related]
19. Bariatric and metabolic surgery and microvascular complications of type 2 diabetes mellitus.
Cohen R; Pechy F; Petry T; Correa JL; Caravatto PP; Tzanno-Martins C
J Bras Nefrol; 2015; 37(3):399-409. PubMed ID: 26398651
[TBL] [Abstract][Full Text] [Related]
20. Impact of bariatric surgery on the development of diabetic microvascular and macrovascular complications.
Goldberg I; Nie L; Yang J; Docimo S; Obici S; Talamini M; Pryor A; Spaniolas K
Surg Endosc; 2021 Jul; 35(7):3923-3931. PubMed ID: 32748271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
